Zeiss questions patent infringement with Signet

San Diego?Carl Zeiss Vision International GmbH and Carl Zeiss Vision Inc. (CZV) have filed a patent infringement lawsuit against Signet Armorlite Inc., San Marcos, CA, in the U.S. District Court for the Southern District of California.

Related Videos

View All

Related Content

International Keratoconus Academy continues to provide cutting-edge education

February 2nd 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

Orbis announces 3-year partnership with HOYA Vision Care

February 2nd 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

ML6710i photodynamic laser for use with VISUDYNE approved by the FDA

February 1st 2023

Pharmacotherapies taking center stage at Angiogenesis, Exudation, and Degeneration 2023

February 1st 2023

International Keratoconus Academy continues to provide cutting-edge education

February 2nd 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

Orbis announces 3-year partnership with HOYA Vision Care

February 2nd 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

ML6710i photodynamic laser for use with VISUDYNE approved by the FDA

February 1st 2023

Pharmacotherapies taking center stage at Angiogenesis, Exudation, and Degeneration 2023

February 1st 2023

International Keratoconus Academy continues to provide cutting-edge education

February 2nd 2023

Commercial real estate and your practice, part two with Colin Carr

May 21st 2022

Orbis announces 3-year partnership with HOYA Vision Care

February 2nd 2023

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

May 12th 2022

ML6710i photodynamic laser for use with VISUDYNE approved by the FDA

February 1st 2023

Pharmacotherapies taking center stage at Angiogenesis, Exudation, and Degeneration 2023

February 1st 2023

Related Content

---

International Keratoconus Academy continues to provide cutting-edge education

Article

---

Commercial real estate and your practice, part two with Colin Carr

Podcast

---

Orbis announces 3-year partnership with HOYA Vision Care

Article

---

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

Podcast

---

ML6710i photodynamic laser for use with VISUDYNE approved by the FDA

Article

---

Pharmacotherapies taking center stage at Angiogenesis, Exudation, and Degeneration 2023

Article